Unknown

Dataset Information

0

Subconjunctival Injection of Viscoelastic Material for Leaking Sclerotomy in Transconjunctival Sutureless Vitrectomy.


ABSTRACT: Aim. To evaluate the effectiveness of subconjunctivally injected viscoelastic material (VEM) for the self-sealing of leaking sclerotomy in transconjunctival sutureless vitrectomy (TSV). Methods. This was a prospective interventional series. Subconjunctival injection of VEM was performed in eyes showing leaking sclerotomy at the end of TSV in selected cases. This procedure was performed in 24 consecutive eyes from 24 patients scheduled for 23- or 25-gauge TSV with phacoemulsification for various vitreoretinal diseases combined with cataracts. Results. Among the 24 eyes, 13 cases were scheduled for 23-gauge TSV, while 11 cases were scheduled for 25-gauge TSV. The average number of injection sites per eye was 1.7 ± 0.9 in the 23-gauge cases and 1.5 ± 0.7 in the 25-gauge cases. Leakage was most commonly observed at the vitrector site of the sclerotomy, while little leakage was observed at the illuminator site. There were no cases of postoperative hypotony. Conclusion. Subconjunctival injection of VEM was simple and effective for the self-sealing of leaking sclerotomy after TSV in selected cases.

SUBMITTER: Lee CH 

PROVIDER: S-EPMC4837269 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Subconjunctival Injection of Viscoelastic Material for Leaking Sclerotomy in Transconjunctival Sutureless Vitrectomy.

Lee Chung Hyun CH   Joe Soo Geun SG   Yang Sung Jae SJ  

Journal of ophthalmology 20160406


Aim. To evaluate the effectiveness of subconjunctivally injected viscoelastic material (VEM) for the self-sealing of leaking sclerotomy in transconjunctival sutureless vitrectomy (TSV). Methods. This was a prospective interventional series. Subconjunctival injection of VEM was performed in eyes showing leaking sclerotomy at the end of TSV in selected cases. This procedure was performed in 24 consecutive eyes from 24 patients scheduled for 23- or 25-gauge TSV with phacoemulsification for various  ...[more]

Similar Datasets

| S-EPMC5742981 | biostudies-literature
| S-EPMC8086054 | biostudies-literature
| S-EPMC4694452 | biostudies-literature
| S-EPMC5368155 | biostudies-literature
| S-EPMC7409383 | biostudies-literature
| S-EPMC5165680 | biostudies-literature
| S-EPMC7719077 | biostudies-literature
| S-EPMC4124000 | biostudies-other
| S-EPMC4346374 | biostudies-literature
| S-EPMC5866566 | biostudies-literature